Cargando…
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Preclinical studies highlighted potential therapeutic applications of aspirin and statins as anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the role of aspirin and statins in the chemoprevention of hepatocellular carcinoma (HCC). However, observational data is...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293618/ https://www.ncbi.nlm.nih.gov/pubmed/35021597 http://dx.doi.org/10.3350/cmh.2021.0366 |